Viewing StudyNCT06055985



Ignite Creation Date: 2024-05-06 @ 7:33 PM
Last Modification Date: 2024-10-26 @ 3:09 PM
Study NCT ID: NCT06055985
Status: RECRUITING
Last Update Posted: 2024-07-12
First Post: 2023-09-20

Brief Title: A Study to Evaluate the Efficacy Safety Tolerability and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinsons Disease
Sponsor:
Organization: UCB Pharma

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 189
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: